Ashraf S. Ibrahim, PhD, outlines safety studies and the potential of this antibody therapy for treating this rare fungal infection, which is seemingly becoming less rare.
Ashraf S Ibrahim, PhD
Advertisement
Senior Investigator at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
Articles by Ashraf S Ibrahim, PhD
Ashraf S. Ibrahim, PhD, details over 20 years of research on a spore-coating protein and the development of VX-01 to block fungal tissue invasion.
Ashraf S. Ibrahim, PhD, discusses how VX-01 prevents fungal invasion of blood vessels and enhances immune response in immunocompromised patients.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Initiatives Look to Strengthen Vaccine Policy and Governance in US
2
European Commission Approves Glecaprevir/Pibrentasvir for Hepatitis C
3
Infectious Disease Regulatory Watch: June Highlights
4
Efflux Pump Inhibitor Restores Azithromycin Activity Against Multidrug-Resistant Gram-Negative Pathogens
5